Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb 11:5:F1000 Faculty Rev-161.
doi: 10.12688/f1000research.7352.1. eCollection 2016.

Recent advances in the understanding and management of IgA nephropathy

Affiliations
Review

Recent advances in the understanding and management of IgA nephropathy

Kar Neng Lai et al. F1000Res. .

Abstract

Since its first description in 1968, IgA nephropathy has remained the most common form of primary glomerulonephritis leading to chronic kidney disease in developed countries. The clinical progression varies, and consequent end-stage renal disease occurs in 30% to 40% of patients 20 to 30 years after the first clinical presentation. Current data implicate overproduction of aberrantly glycosylated IgA1 as being pivotal in the induction of renal injury. Effective and specific treatment is still lacking, and new therapeutic approaches will be developed after better understanding the disease pathogenesis.

Keywords: Familial IgAN; IgA nephropathy; end-stage renal disease; genetics of IgAN; glomerulonephritis; treatment IgAn.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare that they have no competing interests.

No competing interests were disclosed.

References

    1. Kiryluk K, Julian BA, Wyatt RJ, et al. : Genetic studies of IgA nephropathy: past, present, and future. Pediatr Nephrol. 2010;25(11):2257–68. 10.1007/s00467-010-1500-7 - DOI - PMC - PubMed
    1. Hall YN, Fuentes EF, Chertow GM, et al. : Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol. 2004;5:10. 10.1186/1471-2369-5-10 - DOI - PMC - PubMed
    1. Kiryluk K, Li Y, Sanna-Cherchi S, et al. : Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012;8(6):e1002765. 10.1371/journal.pgen.1002765 - DOI - PMC - PubMed
    1. Tam KY, Leung JC, Chan LY, et al. : Macromolecular IgA1 taken from patients with familial IgA nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro. Kidney Int. 2009;75(12):1330–9. 10.1038/ki.2009.71 - DOI - PubMed
    1. Gharavi AG, Moldoveanu Z, Wyatt RJ, et al. : Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol. 2008;19(5):1008–14. 10.1681/ASN.2007091052 - DOI - PMC - PubMed